March 8, 2011 โ Nile Therapeutics is pursuing a new indication for cenderitide, formerly CD-NP. The company is ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
March 8, 2011 โ The U.S. Food and Drug Administration (FDA) announced monthly liver enzyme tests are no longer ...
March 7, 2011 โ Massachusetts General Hospital (MGH) has granted an exclusive license to Santaris Pharma A/S for ...
March 7, 2011 โ Nile Therapeutics will partner with Medtronic to develop natriuretic peptide, cenderitide ...
March 1, 2011 โ The U.S. Food and Drug Administration (FDA) approved azilsartan medoxomil to treat high blood ...
March 1, 2011 โ A new study assessing the utility of genetic testing to determine a personalized warfarin dose ...
February 24, 2011 โ Upsher-Smith Laboratories, is voluntarily recalling one lot (lot #284081) of Jantoven Warfarin ...
Clopidogrel (Plavix) has been the standard antiplatelet therapy for a decade, but it is now facing challenges with ...
February 16, 2011 โ The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous ...
February 10, 2011 โ A Phase 2 clinical trial has been initiated to test the safety and efficacy of drug to reverse ...
January 7, 2011 โ A new study from The Ohio State University found that Protandim can suppress intimal ...
December 29, 2010 - Research on reducing risks, improving medical treatment and improving lifestyle behaviors to ...
December 29, 2010 โ Patient enrollment has been completed for a Phase III trial of an oral Factor Xa inhibitor ...
December 27, 2010 โ The U.S. Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and ...
December 21, 2010 โ A once-daily, three-in-one combination blood pressure treatment has been approved in Germany ...